Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950144-01-507094
Filing Date
2001-09-20
Accepted
2001-09-20 00:00:00
Documents
3
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. g71763a1e10-ka.txt 10-K/A 391096
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP g71763a1ex23-1.txt EX-23.1 646
4 CONSENT OF ERNST & YOUNG LLP g71763a1ex23-2.txt EX-23.2 881
  Complete submission text file 0000950144-01-507094.txt   393927
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-15875 | Film No.: 1741393
SIC: 2834 Pharmaceutical Preparations